Get all your news in one place.
100's of premium titles.
One app.
Start reading
ABC News
ABC News
Health

Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers

Freya and Jackie Goldston say finding out about Fiasp's removal from the PBS was a shock. (ABC Sunshine Coast: Meg Bolton)

For the past six months, 14-year-old Freya Goldston has attended more school, swimming training and increased her time with friends — but that quality of life is now at risk.

Fiasp, the ultra-fast insulin she relies on to treat her type 1 diabetes will be taken off the Pharmaceutical Benefits Scheme (PBS) next month, sending the price soaring.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.